Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 3.392% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) Cc1ccc2[nH]cc(/C=C/c3cc[n+](C)cc3)c2c1.[I-]
b.) COc1ccc(C(=O)NC(C)c2nccs2)cc1OC1CCN(C(C)C)CC1
c.) COc1ccc(C(=O)N(C)Cc2ccc(C)o2)cc1OC1CCN(C(C)C)CC1
d.) Cc1ccc(Cc2nnc(SCC(=O)Nc3ccccc3)n(N)c2=O)cc1
e.) CC(=O)N(C)/C=C1\Sc2ccccc2C1=O
Answer: d. Cc1ccc(Cc2nnc(SCC(=O)Nc3ccccc3)n(N)c2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(Cc2nnc(SCC(=O)Nc3ccccc3)n(N)c2=O)cc1
Cc1ccc(Cc2nnc(SCC(=O)Nc3ccccc3)n(N)c2=O)cc1
2-[[4-amino-6-[(4-methylphenyl)methyl]-5-oxo-1,2,4-triazin-3-yl]sulfanyl]-N-phenylacetamide